Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence

  • Schubiner H
  • Saules K
  • Arfken C
 et al. 
  • 1

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

In this 12-week double-blind placebo-controlled trial of methylphenidate (MTP) versus placebo in 48 cocaine-dependent attention-deficit/hyperactivity disorder (ADHD) adults, the authors sought to determine whether MTP would be safe, control ADHD symptoms, and affect cocaine use. Efficacy indexes revealed significantly greater ADHD symptom relief in the MTP group. There were no group differences in self-reported cocaine use, urinalysis results, or cocaine craving. Because of the relatively small sample size, the results are preliminary. However, we found that MTP improved subjective reports of ADHD symptoms and did not worsen cocaine use while participants were in treatment.

Author-supplied keywords

  • Adolescent
  • Adult
  • Attention Deficit Disorder with Hyperactivity/*dru
  • Central Nervous System Stimulants/adverse effects/
  • Cocaine-Related Disorders/*drug therapy/psychology
  • Comorbidity
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Methylphenidate/adverse effects/*therapeutic use
  • Middle Aged
  • Pemoline/therapeutic use
  • Psychiatric Status Rating Scales

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Authors

  • Howard Schubiner

  • K K Saules

  • Cynthia L. Arfken

  • Chris-Ellyn E Johanson

  • Charles R. Schuster

  • Nancy Lockhart

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free